Konsume
Interval Day Week Month
Author Profile Past 90 Days 23 stories 1 Publishers

jason mast

No author bio on file yet.

Social profiles not yet on file.
jason mast's Coverage
Buzz
Media Coverage
World View

Beat Reporting
Category Articles Share
Health_Medical_Pharma 20
Business_Finance 1
Disaster_Accident 1
Environment 1

Inhibrx claims first win for long-sought immunotherapy target

2026-09-08 — statnews.com


After failure of Angelman syndrome drug, experts see hope in other experimental therapies

2026-09-04 — statnews.com


We're reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more

2026-09-04 — statnews.com


Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial

2026-09-02 — statnews.com


We're reading about drug pricing deals, a new cancer therapy approval, and more

2026-08-31 — statnews.com


FDA pauses Regenxbio gene therapy trial again due to safety concerns 

2026-08-24 — statnews.com


In wake of boy’s death, gene editing experts dissect Huidagene’s decisions

2026-08-19 — statnews.com


Definium Therapeutics says its LSD therapy eased anxiety in late-stage trial

2026-08-12 — statnews.com


Silence Therapeutics aims at Takeda with new data in rare blood cancer

2026-08-10 — statnews.com


Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial

2026-08-10 — statnews.com

Execution: 0.08 Seconds. 52.11 mb used.